Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Orally Administered Pyrophosphate on Calcinosis Formation in Systematic Sclerosis

NCT04966416 is registered in ClinicalTrials.gov with Szeged University as lead sponsor.

NCT NCT04966416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04966416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Orally Administered Pyrophosphate on Calcinosis Formation in Systematic Sclerosis
Lead sponsor
Szeged University
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2023
Completion date
June 30, 2026
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma, systemic sclerosis